Journals / Molecular Imaging and Radionuclide Therapy / 2020 / Cilt: 29 - Sayı: 3

Metabolic Characterization of Anterior Mediastinal Masses by 18F-FDG PET/CT

18F-FDG PET/BT ile Anterior Mediastinal Kitlelerin Metabolik Karakterizasyonu

Pages
105–111
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objectives: To evaluate the role of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnosisof anterior mediastinal masses.Methods: The oncological 18F-FDG PET/CT images of 41 patients (17 women, 24 men; age: 16-83 years, mean age: 50.5±19.5 years) whoattended the nuclear medicine department between November 2016 and September 2017 were retrospectively evaluated for the metaboliccharacterization of their anterior mediastinal masses.Results: Based on our results, the lesions of 4 patients were benign [maximum standard uptake value (SUVmax)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate the role of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnosisof anterior mediastinal masses.Methods: The oncological 18F-FDG PET/CT images of 41 patients (17 women, 24 men; age: 16-83 years, mean age: 50.5±19.5 years) whoattended the nuclear medicine department between November 2016 and September 2017 were retrospectively evaluated for the metaboliccharacterization of their anterior mediastinal masses.Results: Based on our results, the lesions of 4 patients were benign [maximum standard uptake value (SUVmax)
📊
Key Findings & Data:Objectives: To evaluate the role of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnosisof anterior mediastinal masses.Methods: The oncological 18F-FDG PET/CT images of 41 patients (17 women, 24 men; age: 16-83 years, mean age: 50.5±19.5 years) whoattended the nuclear medicine department between November 2016 and September 2017 were retrospectively evaluated for the metaboliccharacterization of their anterior mediastinal masses.Results: Based on our results, the lesions of 4 patients were benign [maximum standard uptake value (SUVmax)
💡
Conclusion & Impact:Objectives: To evaluate the role of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnosisof anterior mediastinal masses.Methods: The oncological 18F-FDG PET/CT images of 41 patients (17 women, 24 men; age: 16-83 years, mean age: 50.5±19.5 years) whoattended the nuclear medicine department between November 2016 and September 2017 were retrospectively evaluated for the metaboliccharacterization of their anterior mediastinal masses.Results: Based on our results, the lesions of 4 patients were benign [maximum standard uptake value (SUVmax)
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate the role of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnosisof anterior mediastinal masses.Methods: The oncological 18F-FDG PET/CT images of 41 patients (17 women, 24 men; age: 16-83 years, mean age: 50.5±19.5 years) whoattended the nuclear medicine department between November 2016 and September 2017 were retrospectively evaluated for the metaboliccharacterization of their anterior mediastinal masses.Results: Based on our results, the lesions of 4 patients were benign [maximum standard uptake value (SUVmax)

Özet

Amaç: Bu çalışmada anterior mediastinal kitlelerin karakterizasyonunda 18F-florodeoksiglukoz (FDG) pozitron emisyon tomografi/bilgisayarlı tomografinin (PET/BT) rolü değerlendirilecektir. Yöntem: Anterior mediastinal kitle tanısıyla nükleer tıp bölümüne Kasım 2016-Eylül 2017 tarihleri arasında metabolik karakterizasyon amacıyla başvuran hastaların onkolojik 18F-FDG PET/BT görüntüleri geriye dönük olarak değerlendirildi. Kırk bir hasta (17 kadın, 24 erkek; 16-83, ortalama yaş: 50,5±19,5) çalışmaya dahil edildi. Bulgular: Çalışmaya dahil edilen hastalardan iki hastanın lezyonu benign olarak tanımlandı [maksimum standart alım değeri (SUVmaks)

🔖

Cite This Article

ARPACI, R. B., KOÇ, Z. P., ÖZCAN, P. P., AYAN, E. (2022). Metabolic Characterization of Anterior Mediastinal Masses by 18F-FDG PET/CT. Molecular Imaging and Radionuclide Therapy, Cilt: 29 - Sayı: 3, 105–111. https://ajindex.com/articles/581560

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gawande, RS, Khurana A, Messing, S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA Daldrup-Link HE. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology 2012;262:613-622
  2. Dua, SG, Purandare, NC, Shah S, Maitra R, Rangarajan V. Cervical extension of the thymus mimicking metastatic recurrence of Ewing sarcoma on PET/CT. Indian J Nucl Med 2010;25:176-177
  3. Sulu E, Damadoğlu E, Takır HB, Okur HK, Köroğlu E, Yılmaz A. A case of endobronchial inflammatory pseudotumor invading the mediastinum. Tuberk Toraks 2011;59:77-80
  4. Proli C, De Sousa P, Jordan S, Anikin V, Devaraj A, Love SM, Shackcloth M, Kostoulas N, Papagiannopoulos K, Haqzad Y, Loubani M, Sellitri F, Granato F, Bush A, Marchbank A, Iyer S, Scarci M, Lim E, UK Thoracic Surgery Research Collaborative. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose ((18)FDG) positron emission tomography (PET)-CT for evaluation of malignancy in anterior mediastinal lesions: the DECiMaL study. BMJ Open 2018;6;8:e019471
  5. Kumar A, Regmi SK, Dutta R, Kumar R, Gupta SD, Das P, Halanaik D, Jindal T. Characterization of thymic masses using (18)F-FDG PET-CT. Ann Nucl Med 2009;23:569-577
  6. Ogawa, M, Hara, M, Ozawa, Y, Moriyama S, Yano M, Shimizu S, Shibamoto Y. Benign metastasizing leiomyoma of the lung with malignant transformation mimicking mediastinal tumor. Clin Imaging 2011;35:401-404
  7. Melloni, G, Carretta, A, Ciriaco, P, Arrigoni G, Fieschi S, Rizzo N, Bonacina E, Augello G, Belloni PA, Zannini P. Inflammatory pseudotumor of the lung in adults. Ann Thorac Surg 2005;79:426-432
  8. Wang, Y, Kalra M, Scott, J. Compensatory asymmetric hemidiaphragmatic uptake secondary to contralateral hemidiaphragmatic paresis. Clin Nucl Med 2013;38:53-55
  9. Srirajaskanthan R, Toubanakis, C, Dusmet M, Caplin ME. A review of thymic tumours. Lung Cancer 2008;60:4-13
  10. Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006;47:1628-1634
  11. De Palma, A, Pagliarulo, V, Lorusso, M, Verardo L, Gennaro FD, Genualdo M, Quercia R, Montrone T, Gentile A, Loizzi M. A rare case of necrotic thymoma. G Chir 2014;35:43-46
  12. Romeo V, Esposito A, Maurea S, Camera L, Mainenti PP, Palmieri G, Buonerba C, Salvatore M. Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. Pol J Radiol 2015;80:22-26
  13. Kaira K,